在严重肥胖的手术患者中,普罗波的药理动力学
Martin Rygh Braathen1,2, Ann E Rigby-Jones3, Johan Ræder1,2
1Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Acta anaesthesiologica Scandinavica
|March 14, 2024
概括
开发了一种新的普罗波的药理动力学 (PK) 模型,准确地描述了它在所有成人体重类别中的行为,包括身体质量指数 (BMI) 非常高的个体. 这种模式增强了不同患者群体的普罗波福尔剂量.
科学领域:
- 药理动力学 药理动力学
- 麻醉学 麻醉学
- 肥胖医学 肥胖医学
背景情况:
- 现有的普罗波 (Propofol) 药理动力学 (PK) 模型对于非常肥胖的患者缺乏足够的数据.
- 需要一个强大的PK模型,适用于成年人体重的全部范围.
研究的目的:
- 开发和验证一个新的群体PK模型用于propofol.
- 纳入来自大量患者队列的数据,包括那些BMI非常高的患者,在标准化外科条件下.
主要方法:
- 使用非线性混合效应建模的人口药理动力学 (PK) 建模.
- 分析了接受手术的69名成年患者的时间度数据.
- 在PK模型中将体重描述符和性别作为共变量纳入.
主要成果:
- 开发了一种三部分的PK模型,将总体重,瘦体重,预测的正常体重和性别作为共同变量.
- 该模型在后期评估中显示出高精度 (1.4%) 和精度 (21.7%).
- 固定的0.75的全度指数改善了模型对空隙参数的性能.
结论:
- 建立了一个新的普罗波PK模型,适用于所有成人体重级别.
- 该模型基于从具有非常高BMI的个体获得的前所未有的数据集.
- 这为在不同患者群体中施用普罗波福尔提供了更可靠的工具.
相关概念视频
Parenteral Anesthetics: Overview
120
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
120
Factors Affecting Drug Distribution: Organ Perfusion Rate
127
Drug distribution within the body is a complex process influenced by several factors, including perfusion rate, the rate at which the bloodstream transports drugs to tissue. This limitation becomes particularly significant when dealing with highly lipophilic drugs. In such cases, the rate at which the drug can move across membranes is crucial, and if the membrane is highly permeable to the drug, distribution becomes rate-limited by perfusion.
Perfusion rate-limited distribution relies on the...
Perfusion rate-limited distribution relies on the...
127
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
134
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
134
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
80
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
80
One-Compartment Open Model for IV Bolus Administration: General Considerations
198
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
198
Local Anesthetics: Pharmacokinetics
759
The potency and duration of action of local anesthetics (LAs) are determined by their pharmacokinetics. Pharmacokinetics describes how LAs are absorbed, distributed, metabolized, and eliminated from the body. When administered to the vascular tissues, LAs are quickly absorbed and enter the systemic circulation, reducing their localized effects. Adding vasoconstrictors such as epinephrine to LAs reduces their absorption into the systemic circulation, making them clinically effective. The...
759


